Filing Details

Accession Number:
0001179110-21-011176
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-21 17:29:21
Reporting Period:
2021-12-20
Accepted Time:
2021-12-21 17:29:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1551152 Abbvie Inc. ABBV Pharmaceutical Preparations (2834) 320375147
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1756865 L Brian Durkin 1 North Waukegan Road
North Chicago IL 60064
Vp, Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Acquisiton 2021-12-20 7,180 $61.36 28,295 No 4 M Direct
Common Stock, $0.01 Par Value Disposition 2021-12-20 11,790 $128.51 16,505 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2021-12-20 7,180 $61.36 7,180 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-02-16 2027-02-15 No 4 M Direct
Footnotes
  1. Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.